55 of a Pan American share in respect of each of their Minefinders shares.
In conjunction, the former Minefinders shareholders who elected the Pan American share option received 0.
47% of the Andean American shares voted at Andean American s annual and special shareholders meeting held earlier today were voted in favour of the special resolution approving the Arrangement.
Trading of Andean American shares is expected to be halted, in advance of closing, after market close on September 25, 2012.
the exchange agent for the transaction, will mail a Letter of Transmittal to each registered shareholder who held Andean American shares immediately prior to completion of the Arrangement.
The analyst has a ``strong buy'' recommendation on North American shares
and a 12-month target price of $15.
After gaining more than 1,000 percent in 1997, North American shares
have been thinly traded and in retreat for much of the past year, owing to investor wariness of the entire brachytherapy sector.
News of the FDA approval sent North American shares
North American shares lost a quarter of their value, dropping $4.
North American shares have lost more than half their value since hitting a six-month high of $30.
North American shares
have been led down by profit-takers who have seen the company's stock rise nearly 700 percent in a year, according to analyst John Calcagnini at CIBC Oppenheimer in Los Angeles.